Why Prostate Cancer Remains a Killer

While prostate cancer is largely considered a highly treatable form of the disease, men still die from it. In fact, this form of cancer is considered the number two most common cancer-related killer of men.

Researchers set out to gain a better understanding of just why this disease that offers early detection protocols and aggressive, effective treatments was still claiming so many lives. To better understand the reason for persistent mortality rates, researchers looked at 190 men with castration-resistant prostate cancer that was metastatic. The study included cases that were treated between 2008 and 2011.

What researchers found was enlightening. A total of 113 of the 190 men died from prostate cancer. Of those who did, all of them had the presence of metastases at initial diagnosis. Of those, 63 patients had detectable metastases with 67 percent, 11 percent and 43 percent having bone, visceral and lymph node metastases, respectively. More research is needed to gain better insights on why initial diagnoses are coming in later stages when cancer has had a better chance to spread.

The research also sheds light on the importance of early and regular screening for prostate cancer. It is generally recommended that men after about the age of 50 begin a screening protocol that includes a simple blood test and a quick physical exam. Although not foolproof, the two can combine to give doctors earlier insights about the presence of prostate cancer.

When detected in its earlier stages, prostate cancer tends to be highly treatable. Men will find a number of treatment options are available to them at earlier stages, including prostate seed implant therapy. This form of therapy can help men avoid surgical complications while providing a highly effective way to battle cancer cell growth.

In an age where prostate cancer is largely treatable, persistent mortality is a concern. Men can help themselves by speaking directly with their healthcare providers about their personal risks and the potential for early screening.

More Choice Cancer Care Centers